A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Clinical trial NCT04685993 · COMPLETED

Trial details

NCT number: NCT04685993
Sponsor: Lipocine Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2020-11-11
Primary completion: 2022-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.